Exagen Inc. (XGN)

USD 5.52

(-4.83%)

Gross Profit Summary of Exagen Inc.

  • Exagen Inc.'s latest annual gross profit in 2023 was 29.45 Million USD , up 37.97% from previous year.
  • Exagen Inc.'s latest quarterly gross profit in 2024 Q2 was 9.05 Million USD , up 5.33% from previous quarter.
  • Exagen Inc. reported a annual gross profit of 21.34 Million USD in annual gross profit 2022, down -22.96% from previous year.
  • Exagen Inc. reported a annual gross profit of 27.71 Million USD in annual gross profit 2021, up 9.03% from previous year.
  • Exagen Inc. reported a quarterly gross profit of 8.59 Million USD for 2024 Q1, up 5.56% from previous quarter.
  • Exagen Inc. reported a quarterly gross profit of 5.3 Million USD for 2023 Q1, down -18.75% from previous quarter.

Annual Gross Profit Chart of Exagen Inc. (2023 - 2012)

Historical Annual Gross Profit of Exagen Inc. (2023 - 2012)

Year Gross Profit Gross Profit Growth
2023 29.45 Million USD 37.97%
2022 21.34 Million USD -22.96%
2021 27.71 Million USD 9.03%
2020 25.41 Million USD 17.78%
2019 21.57 Million USD 26.48%
2018 17.06 Million USD 34.66%
2017 12.67 Million USD 0.0%
2015 8.41 Million USD 76.08%
2014 4.77 Million USD 2023.56%
2013 225 Thousand USD 121.47%
2012 -1.04 Million USD 0.0%

Peer Gross Profit Comparison of Exagen Inc.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD -207.924%
Prenetics Global Limited 8.82 Million USD -233.594%
Star Equity Holdings, Inc. 11.92 Million USD -146.99%
CareDx, Inc 178.32 Million USD 83.482%
Exact Sciences Corporation 1.84 Billion USD 98.404%
Inotiv, Inc. 165.44 Million USD 82.196%
Guardant Health, Inc. 336.89 Million USD 91.257%
Biodesix, Inc. 36.07 Million USD 18.352%
BioNexus Gene Lab Corp. 1.32 Million USD -2115.573%
Precipio, Inc. 6.01 Million USD -389.465%
iSpecimen Inc. 5.1 Million USD -476.674%
Natera, Inc. 492.74 Million USD 94.022%
Aspira Women's Health Inc. 5.26 Million USD -459.787%
Standard BioTools Inc. 50.45 Million USD 41.613%
23andMe Holding Co. 99.37 Million USD 70.359%
Castle Biosciences, Inc. 174.8 Million USD 83.149%
Personalis, Inc. 18.2 Million USD -61.775%
Aclaris Therapeutics, Inc. 13.16 Million USD -123.694%
Applied DNA Sciences, Inc. 5.53 Million USD -432.328%
OpGen, Inc. -90.69 Thousand USD 32578.444%
T2 Biosystems, Inc. -8.17 Million USD 460.539%
Myriad Genetics, Inc. 476.4 Million USD 93.817%
ICON Public Limited Company 1.81 Billion USD 98.376%
NeoGenomics, Inc. 244.6 Million USD 87.958%
Star Equity Holdings, Inc. 11.92 Million USD -146.99%
IDEXX Laboratories, Inc. 2.18 Billion USD 98.655%
RadNet, Inc. 93 Million USD 68.327%
MDxHealth SA 43.92 Million USD 32.946%
Psychemedics Corporation 8.41 Million USD -250.125%
Illumina, Inc. 2.74 Billion USD 98.927%
Check-Cap Ltd. -212 Thousand USD 13994.34%
Twist Bioscience Corporation 133.34 Million USD 77.911%
DarioHealth Corp. 5.98 Million USD -392.246%
Fulgent Genetics, Inc. 104.45 Million USD 71.801%
Sera Prognostics, Inc. 96 Thousand USD -30583.333%
ENDRA Life Sciences Inc. -275.45 Thousand USD 10793.735%
OPKO Health, Inc. 318.12 Million USD 90.741%
Medpace Holdings, Inc. 524.5 Million USD 94.384%
Neogen Corporation 463.9 Million USD 93.65%
Intelligent Bio Solutions Inc. 1.42 Million USD -1966.18%
Prenetics Global Limited 8.82 Million USD -233.594%
Mainz Biomed B.V. 509.65 Thousand USD -5679.551%
bioAffinity Technologies, Inc. 791.61 Thousand USD -3621.001%
Trinity Biotech plc 19.45 Million USD -51.445%
Neuronetics, Inc. 51.7 Million USD 43.031%
Sotera Health Company 577.15 Million USD 94.896%
bioAffinity Technologies, Inc. 791.61 Thousand USD -3621.001%